Change search
ReferencesLink to record
Permanent link

Direct link
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes
German Cancer Research Centre, Germany; Swiss Federal Institute Technology Lausanne EPFL, Switzerland.
Karolinska Institute, Sweden.
German Cancer Research Centre, Germany.
German Cancer Research Centre, Germany.
Show others and affiliations
2015 (English)In: Oncogene, ISSN 0950-9232, E-ISSN 1476-5594, Vol. 34, no 37, 4867-4878 p.Article in journal (Refereed) Published
Abstract [en]

Recent advances in cancer biology have emerged important roles for microRNAs (miRNAs) in regulating tumor responses. However, their function in mediating intercellular communication within the tumor microenvironment is thus far poorly explored. Here, we found miR-206 to be abrogated in human pancreatic ductal adenocarcinoma (PDAC) specimens and cell lines. We show that miR-206 directly targets the oncogenes KRAS and annexin a2 (ANXA2), thereby acting as tumor suppressor in PDAC cells by blocking cell cycle progression, cell proliferation, migration and invasion. Importantly, we identified miR-206 as a negative regulator of oncogenic KRAS-induced nuclear factor-kappa B transcriptional activity, resulting in a concomitant reduction of the expression and secretion of pro-angiogenic and pro-inflammatory factors including the cytokine interleukin-8, the chemokines (C-X-C motif) ligand 1 and (C-C motif) ligand 2, and the granulocyte macrophage colony-stimulating factor. We further show that miR-206 abrogates the expression and secretion of the potent pro-lymphangiogenic factor vascular endothelial growth factor C in pancreatic cancer cells through an NF-kappa B-independent mechanism. By using in vitro and in vivo approaches, we reveal that re-expression of miR-206 in PDAC cells is sufficient to inhibit tumor blood and lymphatic vessel formation, thus leading to a significant delay of tumor growth and progression. Taken together, our study sheds light onto the role of miR-206 as a pleiotropic modulator of different hallmarks of cancer, and as such raising the intriguing possibility that miR-206 may be an attractive candidate for miRNA-based anticancer therapies.

Place, publisher, year, edition, pages
NATURE PUBLISHING GROUP , 2015. Vol. 34, no 37, 4867-4878 p.
National Category
Basic Medicine
URN: urn:nbn:se:liu:diva-121743DOI: 10.1038/onc.2014.408ISI: 000361050000007PubMedID: 25500542OAI: diva2:859360

Funding Agencies|German Federal Ministry of Education and Research (NGFN grant) [01GS0816]; Deutsche Forschungsgemeinschaft (DIP project) [WI3499/1-1]

Available from: 2015-10-06 Created: 2015-10-05 Last updated: 2016-04-25

Open Access in DiVA

fulltext(4371 kB)57 downloads
File information
File name FULLTEXT01.pdfFile size 4371 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Cao, Yihai
By organisation
Division of Cardiovascular MedicineFaculty of Medicine and Health Sciences
In the same journal
Basic Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 57 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 44 hits
ReferencesLink to record
Permanent link

Direct link